{"nct_id":"NCT01767454","title":"Study of Dabrafenib +/- Trametinib in Combination With Ipilimumab for V600E/K Mutation Positive Metastatic or Unresectable Melanoma","status":"COMPLETED","status_verified_date":"2017-11","start_date":"2013-02-12","start_date_type":"ACTUAL","primary_completion_date":"2015-09-04","primary_completion_date_type":"ACTUAL","completion_date":"2015-09-04","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}